Phorbol ester or epidermal growth-factor-induced MUC5AC mucin gene expression and production from airway epithelial cells are inhibited by apigenin and wogonin

Phytotherapy Research

Volumn 26, Issue 12, 2012, Pages 1784-1788

  Kim, Ju Ock ^a   Sikder, Md Asaduzzaman ^b   Lee, Hyun Jae ^b   Rahman, Mustafizur ^c   Kim, Jang Hyun ^d   Chang, Gyu Tae ^e   Lee, Choong Jae ^b  

^a Chungnam National University College of Medicine   (South Korea)

^b Chungnam National University   (South Korea)

^c UNIVERSITY OF DHAKA   (Bangladesh)

^d Dongguk University   (South Korea)

^e Kyung Hee University   (South Korea)

Author keywords

airway mucin; apigenin; MUC5AC; wogonin

Indexed keywords

APIGENIN; EPIDERMAL GROWTH FACTOR; MUCIN 5AC; PHORBOL 13 ACETATE 12 MYRISTATE; WOGONIN;

ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; EPITHELIUM CELL; GENE; GENE EXPRESSION; GENE FUNCTION; HUMAN; HUMAN CELL; MUC5AC GENE; PROTEIN SYNTHESIS; RESPIRATORY EPITHELIUM;

APIGENIN; CELL LINE; EPIDERMAL GROWTH FACTOR; EPITHELIAL CELLS; FLAVANONES; HUMANS; MUCIN 5AC; PHORBOL ESTERS;

EID: 84871295857     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.4650     Document Type: Article

References (26)

1. Cho J, Lee HK,. 2004. Wogonin inhibits ischemic brain injury in a rat model of permanent middle cerebral artery occlusion. Biol Pharm Bull 27: 1561-1564.
2. Choi JR, Lee CM, Jung ID, et al,. 2009. Apigenin protects ovalbumin-induced asthma through the regulation of GATA-3 gene. Int Immunopharmacol 9 (7-8): 918-924.
3. Chun W, Lee HJ, Kong PJ, et al,. 2005. Synthetic wogonin derivatives suppress lipopolysaccharide-induced nitric oxide production and hydrogen peroxide-induced cytotoxicity. Arch Pharm Res 28: 216-219.
4. Clere N, Faure S, Martinez MC, Andriantsitohaina R,. 2011. Anticancer properties of flavonoids: roles in various stages of carcinogenesis. Cardiovasc Hematol Agents Med Chem 9 (2): 62-77.
5. Heo HJ, Kim C, Lee HJ, et al,. 2007a. Carbenoxolone and triterpenoids inhibited mucin secretion from airway epithelial cells. Phytother Res 21 (5): 462-465.
6. Heo HJ, Lee HJ, Kim YS, et al,. 2007b. Effects of baicalin and wogonin on mucin release from cultured airway epithelial cells. Phytother Res 21 (12): 1130-1134.
7. Heo HJ, Lee SY, Lee MN, Lee HJ, Seok JH, Lee CJ,. 2009. Genistein and curcumin suppress epidermal growth factor-induced MUC5AC mucin production and gene expression from human airway epithelial cells. Phytother Res 23 (10): 1458-1461.
8. Hewson CA, Edbrooke MR, Johnston SL,. 2004. PMA induces the MUC5AC respiratory mucin in human bronchial epithelial cells via PKC, EGF/TGF-alpha, Ras/Raf, MEK, REK and Sp1-dependent mechanisms. J Mol Biol 344: 683-695.
9. Hong DH, Petrovics G, Anderson WB, Forstner J, Forstner G,. 1999. Induction of mucin gene expression in human colonic cell lines by PMA is dependent on PKC-epsilon. Am J Physiol 277: G1041-G1047.
10. Illek B, Fischer H,. 1998. Flavonoids stimulate Cl conductance of human airway epithelium in vitro and in vivo. Am J Physiol 275 (5 Pt 1): L902-L910.
11. Jang IM,. 2003. Treatise on Asian Herbal Medicines. Haksul-pyunsu-kwan Research Institute of Natural Products, Seoul National University: Seoul; 477.
12. Ko KH, Lee CJ, Shin CY, Jo M, Kim KC,. 1999. Inhibition of mucin release from airway goblet cells by polycationic peptides. Am J Physiol 277: L811-L815.
13. Lee HJ, Lee SY, Lee MN, et al,. 2011. Inhibition of secretion, production and gene expression of mucin from cultured airway epithelial cells by prunetin. Phytother Res 25 (8): 1196-1200.
14. Li JD, Dohrman AF, Gallup M, et al,. 1997. Transcriptional activation of mucin by Pseudomonas aeruginosa lipopolysaccharide in the pathogenesis of cystic fibrosis lung disease. Proc Natl Acad Sci USA 94 (3): 967-972.
15. Li RR, Pang LL, Du Q, Shi Y, Dai WJ, Yin KS,. 2010. Apigenin inhibits allergen-induced airway inflammation and switches immune response in a murine model of asthma. Immunopharmacol Immunotoxicol 32 (3): 364-370.
16. Paoletti T, Fallarini S, Gugliesi F, Minassi A, Appendino G, Lombardi G,. 2009. Anti-inflammatory and vascularprotective properties of 8-prenylapigenin. Eur J Pharmacol 620 (1-3): 120-130.
17. Park SJ, Kang SY, Kim NS, Kim HM,. 2002. Phosphatidylinositol 3-kinase regulates PMA-induced differentiation and superoxide production in HL-60cells. Immunopharmacol Immunotoxicol 24 (2): 211-226.
18. Rogers DF, Barnes PJ,. 2006. Treatment of airway mucus hypersecretion. Ann Med 38 (2): 116-125.
19. Shao MX, Ueki IF, Nadel JA,. 2003. Tumor necrosis factor alpha-converting enzyme mediates MUC5AC mucin expression in cultured human airway epithelial cells. Proc Natl Acad Sci USA 100: 11618-11623.
20. Tai MC, Tsang SY, Chang LY, Xue H,. 2005. Therapeutic potential of wogonin: a naturally occurring flavonoid. CNS Drug Rev 11: 141-150.
21. Takeyama K, Dabbagh K, Lee HM, et al,. 1999. Epidermal growth factor system regulates mucin production in airways. Proc Natl Acad Sci USA 96: 3081-3086.
22. Takeyama K, Dabbagh K, Jeong Shim J, Dao-Pick T, Ueki IF, Nadel JA,. 2000. Oxidative stress causes mucin synthesis via transactivation of epidermal growth factor receptor: role of neutrophils. J Immunol 164 (3): 1546-1552.
23. Voynow JA, Rubin BK,. 2009. Mucins, mucus and sputum. Chest 135 (2): 505-512.
24. Yu CS, Yu FS, Chuang YC, et al,. 2005. Wogonin inhibits N-acetyltransferase activity and gene expression in human leukemia HL-60 cells. Anticancer Res 25: 127-132.
25. Zhong Y, Krisanapun C, Lee SH, et al,. 2010. Molecular targets of apigenin in colorectal cancer cells: involvement of p21, NAG-1 and p53. Eur J Cancer 46 (18): 3365-3374.
26. Zhou Y, Rajabi H, Kufe D,. 2011. Mucin 1 C-terminal subunit oncoprotein is a target for small-molecule inhibitors. Mol Pharmacol 79 (5): 886-893.